How do I interpret my genomic profiling results for Breast Cancer

Understanding Your Breast Cancer Genomic Profiling Results

Genomic profiling is a powerful tool that analyzes your tumor's DNA to identify specific mutations and characteristics that can guide treatment decisions. Let me walk you through how to interpret these results.

What Genomic Profiling Actually Tests

According to the NCCN Guidelines for Patients: Invasive Breast Cancer, genomic testing looks for:

• Specific DNA mutations in your tumor cells (not inherited mutations)
• Protein levels that affect how cancer cells behave
• Gene expression patterns that reveal how aggressive your cancer is

This is different from genetic testing for inherited mutations like BRCA1/BRCA2—genomic profiling only examines your cancer cells, not your whole body.

---

Key Biomarkers You'll See in Your Report

1. Hormone Receptor Status (ER/PR)

• ER-positive (ER+) = Cancer cells use estrogen to grow → hormone therapy options available
• PR-positive (PR+) = Cancer cells use progesterone to grow
• Hormone receptor-negative (HR-) = Cancer doesn't respond to hormones → different treatment approach

2. HER2 Status

• HER2-positive = High levels of a growth-promoting protein → targeted therapies like trastuzumab (Herceptin) may help
• HER2-negative = Lower levels → different treatment options

3. Actionable Mutations (These are game-changers)

According to the NCCN Guidelines, certain mutations can be targeted with specific drugs:

| Mutation | What It Means | Treatment Possibility | |----------|---------------|----------------------| | PIK3CA | Affects cell growth pathway | Targeted therapy available | | AKT1 | Indicates fast-replicating tumor | CDK4/6 inhibitors may help | | ESR1 | Hormone therapy resistance | Different endocrine therapy options | | PTEN | Loss affects cell growth control | Specific targeted approaches |

---

Understanding Your Test Report: What to Look For

When you receive your genomic profiling results, look for:

✅ Clear mutation list - What mutations were found? ✅ Actionable vs. non-actionable - Which mutations have treatment options? ✅ Confidence levels - How certain is the lab about these findings? ✅ Comparison data - How does your tumor compare to typical breast cancers?

Important Note on Report Complexity

As explained in the CancerPatientLab webinar "An MD PhD Navigates Breast Cancer" by Dr. [removed] Lopez-Correa (an MD PhD who is also a breast cancer patient):

"If you want to see your mutations, if you want to have more granularity... there's no way [to get it from some reports]. You get a PDF report. Thank you very much. You have nothing."

This means: Some reports (like Oncotype DX) give you a score but not detailed mutation information. If you want comprehensive details, ask your doctor about whole genome sequencing or next-generation sequencing (NGS) reports, which provide more granular mutation data.

---

Common Genomic Tests for Breast Cancer

Oncotype DX

• Analyzes 24 genes
• Gives you a recurrence score (0-100)
• Helps decide if you need chemotherapy
• Limitation: Doesn't always show individual mutations

Whole Genome/Exome Sequencing (NGS)

• Analyzes thousands of genes
• Shows specific mutations
• Can reveal actionable mutations Oncotype DX might miss
• More detailed but more complex to interpret

Liquid Biopsy (Circulating Tumor DNA)

• Blood test that detects cancer DNA
• Useful for monitoring disease progression
• Can detect recurrence earlier than imaging
• Note: Still emerging technology—not all oncologists use it yet

---

How to Use Your Results: Questions to Ask Your Doctor

Your genomic results should directly inform your treatment plan. Ask your oncologist:

1. "What mutations were found in my tumor, and which ones are actionable?"

   • Actionable = has a targeted drug available
   • Non-actionable = no specific drug yet, but still provides information

2. "Based on my specific mutations, what treatment options do you recommend?"

   • Don't accept generic answers—your mutations should guide personalized choices

3. "Did my results reveal any mutations that standard testing might have missed?"

   • This is why comprehensive NGS can be valuable

4. "How will you monitor these mutations over time?"

   • Some mutations change with treatment; repeat testing may be needed

5. "Are there clinical trials for my specific mutations?"

   • Emerging treatments target specific mutations

6. "Can I get a copy of my full genomic report with detailed mutation information?"

   • You have the right to understand your own data

---

Real-World Example: What Actionable Mutations Mean

Dr. [removed]-Correa, in her webinar, shared her own experience:

"I have an AKT1 mutation that was detected... The AKT1 is the mutation that was critical for the decision to prescribe CDK6 inhibitors, because that shows... this tumor is replicating fast. This tumor has potentially the possibility for recurrence, because it's an aggressive tumor."

Translation: Her genomic test found a specific mutation (AKT1) that meant her cancer was growing quickly. This finding directly led to a targeted drug (CDK6 inhibitor) that works against that specific mutation.

---

Important Limitations to Understand

✓ Genomic profiling is powerful but not perfect ✓ Not all mutations have treatments yet - science is evolving ✓ Variants of uncertain significance (VUS) - sometimes results show mutations we don't fully understand yet ✓ Tumor heterogeneity - different parts of your tumor may have different mutations ✓ Cost and access - comprehensive testing can be expensive; insurance coverage varies

---

Next Steps: Advocating for Yourself

According to the CancerPatientLab webinar on self-advocacy in precision medicine:

You should:

• Ask about comprehensive genomic profiling (not just standard tests)
• Request detailed mutation reports, not just scores
• Seek genetic counseling to help interpret results
• Don't hesitate to ask for second opinions on treatment recommendations
• Connect with patient communities for support

Know that:

• Not all oncologists routinely order comprehensive genomic testing
• You may need to advocate for testing your doctor hasn't mentioned
• Some tests aren't "standard of care" yet, but that doesn't mean they're not valuable for you

---

Key Takeaway

Your genomic profiling results are a personalized blueprint of your cancer. The mutations found should directly guide which treatments your oncologist recommends. If your doctor can't explain how your specific mutations inform your treatment plan, that's a sign to ask more questions or seek a second opinion.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

---

Authoritative Sources Referenced:

• NCCN Guidelines for Patients: Invasive Breast Cancer (2024)
• NCCN Guidelines for Patients: Metastatic Breast Cancer (2024)
• CancerPatientLab Webinar: "An MD PhD Navigates Breast Cancer" - Catalina Lopez-Correa, MD, PhD
• CancerPatientLab Webinar: "Self-Advocacy in the Era of Precision Medicine" - Rome Madison